Ridruejo E - Search Results

1

Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver.

Villela-Nogueira CA, Ferraz MLG, Pessoa MG, Souto FJD, Nabuco LC, Coelho HSM, Ridruejo E, Silva M, Bittencourt PL, Brandão-Mello CE; Members of the Brazilian Society of Hepatology. Villela-Nogueira CA, et al. Among authors: ridruejo e. Ann Hepatol. 2023 Jan-Feb;28(1):100764. doi: 10.1016/j.aohep.2022.100764. Epub 2022 Sep 28. Ann Hepatol. 2023. PMID: 36182033 Free article.

2

Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon - Ribavirin in daily practice.

Ridruejo E, Adrover R, Cocozzella D, Fernández N, Reggiardo MV. Ridruejo E, et al. Ann Hepatol. 2010 Jan-Mar;9(1):46-51. Ann Hepatol. 2010. PMID: 20308722 Free article.

3

Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study.

Fassio E, Díaz S, Santa C, Reig ME, Martínez Artola Y, Alves de Mattos A, Míguez C, Galizzi J, Zapata R, Ridruejo E, de Souza FC, Hernández N, Pinchuk L; Multicenter Group for Study of Hepatocarcinoma in Latin America; Asociación Latinoamericana para el Estudio del Hígado (ALEH). Fassio E, et al. Among authors: ridruejo e. Ann Hepatol. 2010 Jan-Mar;9(1):63-9. Ann Hepatol. 2010. PMID: 20332549 Free article.

4

Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C.

Ridruejo E, Díaz C, Michel MD, Soler Pujol G, Martínez A, Marciano S, Mandó OG, Vilches A. Ridruejo E, et al. Ann Hepatol. 2010 Jul-Sep;9(3):271-7. Ann Hepatol. 2010. PMID: 20720267 Free article.

5

Thioctic acid-induced acute cholestatic hepatitis.

Ridruejo E, Castiglioni T, Silva MO. Ridruejo E, et al. Ann Pharmacother. 2011 Jul;45(7-8):e43. doi: 10.1345/aph.1Q035. Epub 2011 Jun 13. Ann Pharmacother. 2011. PMID: 21672886

6

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.

Ridruejo E, Adrover R, Silva MO. Ridruejo E, et al. Hepatology. 2011 Sep 2;54(3):1104-5; author reply 1105. doi: 10.1002/hep.24498. Hepatology. 2011. PMID: 21721024 No abstract available.

7

Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice.

Ridruejo E, Adrover R, Cocozzella D, Reggiardo MV, Estepo C, Schroder T, Paz S, Mendizábal M, Fainboim H, Mandó OG, Silva MO. Ridruejo E, et al. Int J Clin Pract. 2011 Aug;65(8):866-70. doi: 10.1111/j.1742-1241.2011.02719.x. Int J Clin Pract. 2011. PMID: 21762311

8

Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin.

Ridruejo E, Solano A, Marciano S, Galdame O, Adrover R, Cocozzella D, Delettieres D, Martínez A, Gadano A, Mandó OG, Silva MO. Ridruejo E, et al. Ann Hepatol. 2011 Oct-Dec;10(4):452-7. Ann Hepatol. 2011. PMID: 21911885 Free article.

9

Entecavir in the treatment of chronic hepatitis B in kidney transplantation.

Ridruejo E, Adrover R, Mandó OG, Silva MO. Ridruejo E, et al. J Hepatol. 2012 Apr;56(4):997-8; author reply 999. doi: 10.1016/j.jhep.2011.09.019. Epub 2011 Nov 7. J Hepatol. 2012. PMID: 22075262 Free article. No abstract available.

10

Safety of long-term nucleos(t)ide treatment in chronic hepatitis B.

Ridruejo E, Silva MO. Ridruejo E, et al. Expert Opin Drug Saf. 2012 May;11(3):357-60. doi: 10.1517/14740338.2012.672972. Epub 2012 Mar 15. Expert Opin Drug Saf. 2012. PMID: 22417072

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page